To analyze whether MET high-level amplification may represent a late event in the carcinogenesis, we have performed FISH for MET on 25 independent cases of therapy-naive resection specimens of non-small-cell lung cancer in early stage: in none of them a high-level amplification is detectable. This evidence concerns the gene MET and non-small cell lung carcinoma.